Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer
Clinical trial NCT02546531 · COMPLETED
Trial details
- NCT number
- NCT02546531
- Sponsor
- Washington University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-03
- Primary completion
- 2017-11-17
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.